Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -8.95 is 65% above its 5-year average of -25.33, near the high end of its 5-year range (-52.50–-4.32).
6.29% below its 12-month average of -8.42.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.34.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 25 comparable quarters.
EARNINGS PER SHARE (EPS)
-8.95
EARNINGS PER SHARE (EPS) AVG TTM
-8.42
EARNINGS PER SHARE (EPS) AVG 3Y
-12.89
EARNINGS PER SHARE (EPS) AVG 5Y
-25.33
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-6.29%
CURRENT VS 3Y AVG
+30.55%
CURRENT VS 5Y AVG
+64.66%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Dogwood Therapeutics, Inc.
Market Cap
$52.46M
Earnings Per Share (EPS)
-8.95
TTM Avg
-8.42
3Y Avg
-12.89
5Y Avg
-25.33
Market Cap
$52.47M
Earnings Per Share (EPS)
-1.00
TTM Avg
-1.43
3Y Avg
-2.38
5Y Avg
-2.90
Market Cap
$51.70M
Earnings Per Share (EPS)
N/A
TTM Avg
-7.29
3Y Avg
-67.66
5Y Avg
-178.24
Market Cap
$51.42M
Earnings Per Share (EPS)
-1.20
TTM Avg
-0.91
3Y Avg
-0.56
5Y Avg
-0.48
Market Cap
$51.36M
Earnings Per Share (EPS)
-0.27
TTM Avg
-0.75
3Y Avg
-1.03
5Y Avg
-0.90
Market Cap
$50.96M
Earnings Per Share (EPS)
-0.67
TTM Avg
-1.36
3Y Avg
-1.71
5Y Avg
-1.31
Market Cap
$50.80M
Earnings Per Share (EPS)
-0.69
TTM Avg
-1.98
3Y Avg
-1.79
5Y Avg
-1.67
Market Cap
$53.80M
Earnings Per Share (EPS)
-5.21
TTM Avg
-25.08
3Y Avg
-23.14
5Y Avg
-19.79
Market Cap
$51.56M
Earnings Per Share (EPS)
-3.55
TTM Avg
-4.16
3Y Avg
-5.92
5Y Avg
-5.28
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | $52.46M | -8.95 | -8.42 | -12.89 | -25.33 |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $52.47M | -1.00 | -1.43 | -2.38 | -2.90 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.70M | N/A | -7.29 | -67.66 | -178.24 |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | -1.20 | -0.91 | -0.56 | -0.48 |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.36M | -0.27 | -0.75 | -1.03 | -0.90 |
| Envoy Medical, Inc. (COCH)vs › | $50.96M | -0.67 | -1.36 | -1.71 | -1.31 |
| INmune Bio, Inc. (INMB)vs › | $50.80M | -0.69 | -1.98 | -1.79 | -1.67 |
| ImageneBio Inc (IMA)vs › | $53.80M | -5.21 | -25.08 | -23.14 | -19.79 |
| Clene Inc. (CLNN)vs › | $51.56M | -3.55 | -4.16 | -5.92 | -5.28 |
| Microbot Medical Inc. (MBOT)vs › | $50.36M | -0.26 | -0.51 | -0.97 | -1.13 |
Trailing EPS (TTM)
$-8.95
Forward EPS (Est.)
$-0.87
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -4.32 |
| 2024-12-31 | -12.52 |
| 2023-12-31 | -7.05 |
| 2022-12-31 | -27.66 |
| 2021-12-31 | -47.90 |
| 2020-12-31 | -52.50 |
| 2019-12-31 | -12.80 |
| 2018-12-31 | -10.93 |
